Morgan Lewis

Life Sciences Protecting the Complete Life Cycle

For More Information

Read the Brochure

Life Sciences and Healthcare

New Resource

Healthcare Policy and Reform Resource Center

Life Sciences Deskbook

Compliance Resources

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Honors

LMG Life Sciences’s Healthcare Pricing and Reimbursement Firm of 2013

LMG Life Sciences 2013

  • Antitrust – Highly Recommended
  • Competition and Antitrust – Recommended
  • Corporate – Highly Recommended
  • FDA & Pharmaceutical – Recommended
  • General Patent Litigation – Recommended
  • Government Investigation/Fraud & Abuse – Highly Recommended
  • Healthcare: Pricing & Reimbursement – Recommended
  • Licensing & Collaboration (non-university) – Highly Recommended
  • Life Cycle Firm of the Year
  • Mega-Mergers – Recommended
  • Patent Prosecution – Recommended

Chambers Global 2013

  • Global Life Sciences – Recommended, Band 3

Chambers USA 2013

  • National for Life Sciences – Tier 3
  • Washington, D.C., for Healthcare – Pharmaceutical/Medical Products Regulatory – Tier 3

American Health Lawyers Association (AHLA) 2013

  • Top 20 largest U.S. AHLA firm
  • Largest AHLA firm in Pennsylvania
  • One of the largest firms participating in the AHLA Practice Groups of Labor and Life Sciences

Modern Healthcare 2013

  • Ranked 2nd in the Healthcare Law Firms Survey

PLC Cross-border 2012 Life Sciences Legal Market Review

  • Life Sciences Super League – Ranked 14th of law firms worldwide
  • Life Sciences Regulatory Super League – Ranked 8th of law firms worldwide

PLC Life Sciences Multi-Jurisdictional Guide 2012

United States:

  • Commercial and Partnering – Highly Recommended
  • Competition/Antitrust – Highly Recommended
  • Corporate – Recommended
  • Government Enforcement and Investigations – Highly Recommended
  • Pricing and Reimbursement – Recommended
  • Regulatory – Recommended
  • Regulatory (Medical Devices) – Recommended

England:

  • Regulatory – Highly Recommended

Japan:

  • Corporate and Commercial – Recommended

Clients

17 of the top 20 pharmaceutical companies

8 of the top 20 biotechnology companies

13 of the top 20 medical device companies

Practice Highlights

Related Events

05/04/14-05/07/14 MAGI's Clinical Research Conference - 2014 East
Gary Yingling, speaker, "FDA Inspections: Handling the Consequences"
View all events

Related News

03/14/14 Morgan Lewis Partner Awarded Pennsylvania Bio’s President’s Service Award
Business and Finance Partner Steve Jannetta was awarded the President’s Service Award at the Pennsylvania Bio (PA Bio) Annual Dinner and Awards Celebration
01/01/14 Life Sciences Cases To Watch In 2014, Law360
Life Sciences partner Stephen Paul Mahinka comments on the FTC v. Cephalon , the FTC's challenge on pay-for-delay agreements restricting generic drug market entry.
10/03/13 Morgan Lewis Receives 2013 LMG Life Sciences Awards
Morgan Lewis was named Healthcare Pricing and Reimbursement Firm of the Year at the inaugural LMG Life Sciences awards ceremony.
View all news

Related Publications

03/27/14 Medical Device Update: FDA Issues Proposed Regulations on Medical Device Classification and Reclassification to Streamline the Process
The Food and Drug Administration (FDA) issued proposed regulations on March 25, 2014 to implement Food and Drug Administration Safety and Innovation Act (FDASIA) provisions enacted in July 2012 on medical device classification and reclassification.
03/12/14 Medical Device Update: FDA Releases Final Pre-Submission Guidance
The new guidance includes requirements on the type, timing, format, and content of requests for feedback meetings and telephone conferences with FDA. Therefore, it will be important for the medical device industry to be aware of these requirements in planning their device development activities and timelines.
View all publications

Comprising more than 175 partners and counsel located in the United States, Europe, and Asia, Morgan Lewis’s Life Sciences and Healthcare Practice is one of the most comprehensive practices in the world—serving more than 1,100 clients throughout the complete product life cycle and in all facets of industry issues. The strength of our team is supported by more than 50 professionals holding advanced scientific degrees.

Our clients include many of the largest and most successful pharmaceutical companies in the world, as well as a variety of biotechnology companies, medical device manufacturers, nutritional companies, healthcare providers, renowned research and scientific institutions, and life sciences–focused investment banks and venture capital firms. As diverse as they are, these companies share a common need for comprehensive, integrated legal services that address all of the business challenges and opportunities facing the industry.

Our Life Sciences and Healthcare Practice focuses on all important areas, from transactions and litigation to regulatory approvals and compliance and protection of intellectual property, as well as key supporting capabilities, including FDA and healthcare, patents and patent litigation, labor and employment law, Morgan Lewis Resources workplace training and immigration, and antitrust. As a full-service firm with offices in the financial and regulatory centers of importance to the industry globally, we are consistently recognized as an industry leader by Chambers USA, Chambers Global, Modern Healthcare, The Legal 500, and other industry observers.